Core Viewpoint - UBS has raised its profit forecasts for Hengan International (01044) for 2025 to 2027 by 1% to 4% and revenue forecasts by 1% to 2%, increasing the target price from HKD 27.7 to HKD 29.5 while maintaining a "Buy" rating [1] Financial Performance - For the first half of 2025, Hengan's revenue and net profit are expected to decline by 0.2% and 2.6% respectively, with a projected net profit drop of approximately 12% when excluding foreign exchange gains, which is largely in line with UBS's expectations [1] - The tissue paper business saw a year-on-year revenue growth of 3%, while the sanitary napkin business experienced a year-on-year decline of 14% [1] Management Insights - Management indicated that the performance of wet wipes is stable, and the competitive landscape in the tissue paper market is better than expected, although sales of sanitary products and mid-to-low-end diapers have declined due to intensified competition [1] Future Outlook - The group anticipates steady growth in tissue paper sales, with an expected improvement in the gross margin of sanitary products in the second half of 2025 [1]